KALIN HUEFTLE: Open Payments
NPI 1285493544 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,095 in 93 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,033 · 2025 $2,095
Food & beverage: $2,095
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $382 |
| ABBVIE INC. | 19 | $351 |
| Novo Nordisk Inc | 12 | $289 |
| Amgen Inc. | 10 | $225 |
| PFIZER INC. | 11 | $200 |
| Lilly USA, LLC | 7 | $119 |
| Corcept Therapeutics | 1 | $109 |
| Astellas Pharma US Inc | 2 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $60 |
Products named: BREZTRI, Ozempic, VRAYLAR, ELIQUIS, MOUNJARO, AIRSUPRA, Korlym, KRYSTEXXA.
Industry payments across NV — which companies pay providers there.
